Over the past 10 years, the orginal rtnership 
The gold standard of clinical research, the controlled, prospective trial (Gelber & Goldhirsch, 1988) from phase I to phase III, is invariably a collaborative, multidisciplinary pro- ject. Any trial is a major and costly enterprise, frequently taking many years to complete. Success depends upon correct design, careful planning, meticulous execution and provision of adequate resources. Once the basic protocol has been agreed, the actual execution becomes largely a matter of teamwork and good administration. To detect small but beneficial improvements in treatment outcome, large numbers of patients are required, and hence trials, especally of adjuvant therapy, are becoming larger and almost universally multicentre. Over the past 10 years, the original parnership of clinkian and statistician has come to be supplemented by a new professional -the trial coordinator or data managerwho is responsible for running the study. As Warlow (1990) has written, these generalists who specialise in 'maing it work' are key personnel with a wide range of disparate sklills. Increasing numbers are employed with a range of experience, expertise and responsibilities, from the speciast clerk (data manager) through to the fully fledged project scientist/ manager (trial coordinator), and are to be found within many different environments: dedicated clinical trials centres, specialist oncology departments and district geneal hospitals. Tbeir involvement in clinical research and trials in parbcular can range from the tightly controlled phase I/IH drug development trials to the large, more pragmatic, phase Ill treatment evaluation trials. This is a new and still developing profession that is coming of age in a time of change and uncertainty over the future of medical research (Ward, 1992; Sonhami, 1993 (Pocock, 1983; Fowkes et al., 1991) . Performing good, controlled scientific studies in human subjects is a very complex area. It is widely accepted that the design, coordination and analysis of modem trials requires a multidisciplinary specialist approach. In the UK, there are a number of specialist trials offices primarily funded by the cancer charities (CRC and ICRF) and the Medical Research Council (MRC), each with specific remits.
The editorial policy of many scientific journals now emphasises the importance of statistical input and correct analyses. Since good results can never be extracted from poor data, it is perhaps surprising that the acceptance of the need for professional data managers and trial coordinators has lagged behind that of defined statistical methods (Neaton et al., 1990) . Historically, data management staff were co-opted from other fields with a variety of backgrounds -nursing, secretarial, computing and basic research to name but four. (Vantongelen et al., 1989 (Vantongelen et al., , 1991 Meharchand & Tannock, 1991 Throughout the UK, as elsewhere, the pattern of development is one of gradual centralisation of key resources and skills through the creation of specialist centres for data management and statistics. However, the current position is that many data managers are employed independently within hospital departments, rather than having links with specialist centres. Under the new purchaser/provider arrangements within the NHS, demand for data management support for the additional work involved in participating in trials can be expected to increase. Since it is this group who are potentially most isolated, they have the greatest need for training and thus the most to gain from BODMA. (Farrar, 1991) . In order to offer job satisfaction and provide the expected quality of data management the 'on-site' data collectors should have relevant experience and could be affiliated to an appropriate trials centre for supervision and training. In the USA, the NSABP and ECOG groups have achieved considerable success in recruiting through the 'outreach model', which places staff and resources within community centres.
Other groups too report the success of the multicentre collaborative team approach (Begg et al., 1982; Fleming, 1989; Freedman, 1989; Friedman & Cain, 1990; Farrar, 1991; Franklin et al., 1992) . They have also seen improvement in data quality and an increased acceptance of methodology as results penetrate into practice. The data managers concerned benefit from the training, newsletters, quality control and supervision which the specialist centre provides.
The situation in the UK is moving towards a point where such a model could begin to be implemented here, perhaps funded through the auspices of the UKCCCR or new DOH research initiatives and admin using the existing network of trials centres which geographically cover the UK.
We could invest resources in establishing a national network of 'on-site' local personnel within hospitals to enable them to recruit reasonable numbers of patients into trials of major national interest (Souhami, 1993) . It would require extensive collaboration and goodwill to set up the initial structure and mechanisms, but the potential benefits should easily repay the effort. Funding for such posts could be shared between a number of different studies/funding bodies in order to create more secure positions. Such a scheme could initially consolidate existing posts, especially those whose holders' experience and expertise would be missed most from the 'pool' upon the curtailment of a short-term contract. Seventy per cent of current BODMA members have no security of tenure and are employed on short-term contracts.
Data managers such as these would be attached to the nearest or most appropriate trials centre for purposes of training, personal development, etc. They might be expected to visit more than one hospital in the area and could pro-mote several protocols, even for different trials groups. The sharing of resources and experience between trials and the possible projected increase to recruitment into trials should make it cost-effective in the long term.
Career development and training BODMA produces a biannual newsletter, and since 1987 BODMA has organised sLx national annual meetings. Regional meetings and workshops have also been held. The overriding aim in all of these is to improve the 'quality of clinical trials and raise standards for data managers and trial coordinators alike. Most members have now had the opportunity to visit the larger clinical trials centres in their area, and informal links are being formed between the peripatetic data manager and the specialist trials centres.
A centrally coordinated network of data managers and trial coordinators would have advantages for training programmes and establishing a career sructure. Currently very few relevant courses are available, which results in virtually all new team members at whatever level receiving no appropriate training. BODMA members have a wide variety of backgrounds, interests, abilities and aspirations. Sadly though, many experienced trial coordinators and data managers are leaving the 'profession' because of lack of direction, a shortage of senior positions and uncertainty over funding. Only 34% (32) of members have been employed within this field for more than 4 years, and 31% (29) for less than 2. The latter figure of 31% does not reflect an increase of new posts as our total membership has remained relatively static at 170 for the last few years. A career structure, however, relies upon a good training programme, universally recognised levels of knowledge and expertise and the desire to stay within the established framework.
BODMA has identified the training/learning requirements of data managers and trial coordinators as falling into five categories: 1. Induction courses for new trial coordinators and data managers, covering areas related to the rationale of clinical trials and practical aspects for data management. 2. Specialised in-depth workshops for more experienced trial coordinators and data managers in key areas such as trial methodology, database management, presentation skills, statistics and site-specific aspects (e.g. breast, gynaecological), such as risk/prognostic factors, natural history, current treatment regimens plus quality of life issues. 
